Viridian Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
All right. Good afternoon. Let's kick off our next session. It is my pleasure to host Viridian Therapeutics. And with me, we have Steve Mahoney and Shan Wu, CEO and CBO of the company.
So a lot to talk about, very, very exciting year. But before we go do it, I'm going to kick it off to Steve and Shan for opening remarks.
()
Yeah. Thanks, Rich. Thanks for having us. We appreciate it. We are on the verge of commercial approval. We have a PDUFA date of June 30, so very short time period until we expect to be on the market. All of our regulatory interactions have been consistent and positive and give us a lot of confidence going into that PDUFA date. We are right on track with everything.
So that's exciting. We can talk about launch dynamics and that type of thing in more detail as we go. We obviously also had our top-line readout from our subcutaneous studies, REVEAL
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
